Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Two issues should be noted whe...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19

Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19

Bibliographic Details
Main Authors: Wenping Gong, Yinping Liu, Yong Xue, Li Zhuang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Bacillus Calmette-Guérin (BCG)
tuberculosis (TB)
COVID-19
clinical trial
latent tuberculosis infection (LTBI)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1207212/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1207212/full

Similar Items

  • Vaccination-related Mycobacterium bovis BCG Infection
    by: Anna Liberek, et al.
    Published: (2006-05-01)
  • A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
    by: V.L. Petricevich, et al.
    Published: (2001-01-01)
  • The Interferon-Gamma Release Assay versus the Tuberculin Skin Test in the Diagnosis of <i>Mycobacterium tuberculosis</i> Infection in BCG-Vaccinated Children and Adolescents Exposed or Not Exposed to Contagious TB
    by: Magdalena Druszczynska, et al.
    Published: (2023-02-01)
  • Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
    by: Roberta Monardo, et al.
    Published: (2025-01-01)
  • Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
    by: Jingli Du, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs